← Back
$AUPH All transactions

Aurinia Pharmaceuticals Inc.

▲ BUY
7 / 10

Conviction

$ Value

$1.2M

Shares

83,561

Price

$14

Filed

Mar 3

Why this score? (7/10)
  • Open market buy (+3)
  • Trade value >= $1.0M (+2)
  • Director (+1)
  • Not a 10b5-1 plan (+1)

Insider

Name

TANG KEVIN

Title

CIK

0001178579

Roles

Director

Transaction Details

Transaction Date

2026-03-02

Code

P

Table

Non-Derivative

Ownership

Indirect

Equity Swap

No

Shares After

11,929,500

Footnotes

The prices reported are weighted-average prices. These shares were purchased in multiple transactions at prices ranging from $13.51 to $14.23. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the SEC staff, upon request, all information regarding the number of shares purchased at each price within the ranges set forth in Footnotes 1 and 3 through 7. | Tang Capital Partners, LP ("TCP") beneficially owns 6,990,461 shares and Tang Capital Partners International, LP ("TCPI") beneficially owns 5,239,039 shares. Kevin Tang is the sole manager of Tang Capital Management, LLC, which is the general partner of TCP and TCPI. Mr. Tang has a pecuniary interest in the shares beneficially held by TCP and TCPI. | These shares were purchased in multiple transactions ranging from $14.00 to $14.18. | These shares were purchased in multiple transactions ranging from $14.35 to $14.61. | These shares were purchased in multiple transactions ranging from $14.04 to $14.50. | These shares were purchased in multiple transactions ranging from $14.14 to $14.33. | These shares were purchased in multiple transactions ranging from $13.97 to $14.39.

Filing Info

Accession No.

0001178579-26-000001

Form Type

4

Issuer CIK

0001600620

TANG KEVIN's History

Date Ticker Type Value
2026-03-03 AUPH $2.6M
2026-03-02 AUPH $1.2M
2026-03-02 AUPH $1.6M
2026-02-27 AUPH $4.2M
2026-02-27 AUPH $3.0M
2026-02-27 AUPH $23K
2025-08-05 AUPH $2.3M
2025-08-04 AUPH $1.1M
2025-08-01 AUPH $10.1M

Other Insiders at AUPH (90d)

Insider Bought Sold Last
TANG KEVIN $11.5M 2026-03-03
Greenleaf Peter
Chief Executive Officer
2026-03-02
Donley Matthew Maxwell
Chief Operating Officer
2026-03-02
Miller Joseph M
Chief Financial Officer
2026-03-02
Robertson Stephen P.
EVP, General Counsel
2026-03-02
Keenan Greg
SVP, Chief Medical Officer
2026-03-06